MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2024 International Congress

    The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

    L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

    Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…
  • 2024 International Congress

    Characterizing Dopaminergic Correlates of Depression in Parkinson’s Disease: The PPMI Cohort

    C. Song, A. Basu, I. Bedoy, J. Li, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: We explored the association between cerebrospinal fluid (CSF) dopamine metabolites and transporter denervation in the development of depression in Parkinson Disease (PD). Background: Depression…
  • 2024 International Congress

    Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor

    L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble (Boston, USA)

    Objective: Develop and validate a TETRAS PRO subscale Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but…
  • 2024 International Congress

    The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

    A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)

    Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…
  • 2024 International Congress

    Assessing the Accuracy of Clinical features, CSF Dopamine Metabolites, and Striatal Binding Ratios for the Likelihood of Depression Over 10-year Follow Up in the PPMI Cohort.

    J. Li, A. Basu, C. Song, I. Bedoy, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: To identify whether MDS-UPDRS scores, Dopamine Transporter (DaT) Striatal Binding Ratios (SBRs), or dopamine metabolites cerebrospinal fluid (CSF) concentrations could predict the likelihood of…
  • 2024 International Congress

    Social phobia, anxiety and depression in patients with essential tremor

    S. Shtaimets, а. Shtraub, N. Zhukova, YU. Lalov, L. Tkachenko, I. Zhukova, A. Agasheva, D. Novotnyy (Omsk, Russian Federation)

    Objective: ET is the most diagnosed movement disorder, the frequency of which increases as a person ages. Background: To examine the incidence of social phobia,…
  • 2024 International Congress

    Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort

    L. Smith, X. Li, A. Gill, P. Panzarasa, J. Bestwick, A. Schrag, A. Noyce, A. de Simoni (London, United Kingdom)

    Objective: This study aims to:(1) Explore the feasibility of delivering a web application to enable social interaction and analyse digital social characteristics.(2) Gather insights into…
  • 2024 International Congress

    The comorbidity conundrum in functional movement disorder: How are FMD patients with additional other FND different?

    S. Desai, A. Shah, D. Desai (Anand, India)

    Objective: This study aimed to compare patients with isolated Functional Movement Disorders [FMD-i] to those with associated co-morbid other Functional Neurological Disorders(FND) [FMD+]. Background: FMD…
  • 2023 International Congress

    Incidence of Parkinson’s disease and modifiable risk factors in Korean population: A longitudinal follow-up study of a nationwide cohort

    SJ. Chung, SH. Kang, S-J. Moon, M. Kang, GJ. Cho, S-B. Koh (Goyang, Republic of Korea)

    Objective: We aimed to investigate the incidence of Parkinson’s disease (PD) by age and year for each sex as well as the modifiable risk factors…
  • 2023 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers

    C. Marras, D. Weintraub, J. Beck, A. Naito, Z. Meyer, N. Dahodwala, T. Davis, K. Mills, J. Miyasaki, S. Mantri, M. Neault, A. Brown, A. Allen, E. Nelson, H. Liu (Toronto, Canada)

    Objective: Implement depression screening using a validated instrument for people with Parkinson’s (PWP) as part of standard of care in the specialist movement disorders setting…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley